1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ADAPTIVE BIOTECHNOLOGIES CORP
Adaptive Biotechnologies Corp XNAS: ADPT

Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

Read More
15.91 -0.33 (-2.03%)
166.95% Gain from 52W Low
1.1M
XNAS Volume

XNAS 02 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Adaptive biotech Corp is on 12 Jan 2026 for the purpose of Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
9.3 / 100
Momentum Score
Technically Neutral
50.5 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
20
1Yr Price target upside is 25%
7 analysts

10

S

15

W

2

O

1

T

SWOT Analysis

Adaptive biotech Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..